Skip to main content
Premium Trial:

Request an Annual Quote

Bioinformatics in the Bear Market: How are Public Companies Doing?

Premium

With the sharp downturn in the financial markets, BioInform decided to take a look at how bioinformatics stocks were faring. Unfortunately, the news isn’t good. Shares of all five of the bioinformatics companies that went public in 2000 are currently trading below the closing price on their first day of trading.

Of course, these companies still have something to smile about — they’ve got loads of IPO cash in the bank. Other bioinformatics companies such as DoubleTwist and NetGenics have withdrawn their offerings and undergone layoffs as they try to ride out the storm as privately held companies.

File Attachments

Filed under

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.